An adaptive design for updating the threshold value of a continuous biomarker-Reference-Cited by-同舟云学术

An adaptive design for updating the threshold value of a continuous biomarker

Published:2016-07-14 Issue:27 Volume:35 Page:4909-4923
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Spencer Amy V.¹,Harbron Chris²,Mander Adrian³^ORCID,Wason James³,Peers Ian¹

Affiliation:

1. AstraZeneca, Global Medicines Development; Biometrics and Information Sciences; Mereside, Alderley Park Macclesfield SK10 4TG U.K.

2. Roche Pharmaceuticals; 6 Falcon Way Welwyn Garden City AL7 1TW U.K.

3. MRC Biostatistics Unit Hub for Trials Methodology Research, Cambridge Institute of Public Health; Cambridge Biomedical Campus; Forvie Site, Robinson Way Cambridge CB2 0SR U.K.

Funder

Medical Research Council

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference21 articles.

1. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers;Fong;New England Journal of Medicine,2009

2. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation;Kaufman;Journal of Clinical Oncology,2015

3. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial;Tutt;The Lancet,2010

4. Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset;Wang;Pharmaceutical Statistics,2007

5. A conditional error function approach for subgroup selection in adaptive clinical trials;Friede;Statistics in Medicine,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Two-Stage Covariate-Adjusted Response-Adaptive Enrichment Design;Statistics in Biopharmaceutical Research;2024-02-26

2. Optimal design for inference on the threshold of a biomarker;Statistical Methods in Medical Research;2024-01-31

3. New insights into adaptive enrichment designs;Statistical Papers;2023-03-31

4. IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy;BMC Medical Research Methodology;2023-03-20

5. Design considerations for two‐stage enrichment clinical trials;Biometrics;2022-12-13